| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.23 | 0.09 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.1 |